Certified by Founder Lodge
Latus Bio
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $54,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Latus Bio is a post-platform company with proprietary technologies to identify and engineer novel AAV capsid variants with unprecedented potency, specificity, and develop ability, screening d
DCVC Bio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
